Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
UGT1A3 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors
APC - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ERLIN1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
HSPG2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SEPT2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ADGRG1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
POLR2C - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
DAG1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
NFE2L2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GPR174 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
IFT57 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
IMPAD1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
RAB15 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
NFYC - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
RAB1A - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
FARSA - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
OR2M4 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
FAAP100 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
LPIN2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on